Hair Regrowth Promotor Pharmaceutical Minoxidil CAS 38304-91-5 for Hair Regrowth CAS NO.38304-91-5

Hair Regrowth Promotor Pharmaceutical Minoxidil CAS 38304-91-5 for Hair Regrowth

Minoxidil is a vasodilator medication known for its ability to slow or stop hair loss and promote hair regrowth. It is available over the counter for treatment of androgenic alopecia, among other baldness treatments, but measurable changes disappear within months after discontinuation of treatment. Its effectiveness has largely been demonstrated in younger men (18 to 41 years of age), the younger the better, and in those with balding in the central (vertex) portion of the scalp.

Minoxidil was the first drug approved for the treatment of androgenetic alopecia (hair loss). Before that, minoxidil had been used as vasodilator drug prescribed as oral tablet to treat high blood pressure, with side effects that included hair growth and reversal of male baldness. In the 1980s, UpJohn Corporation came out with a topical solution of 2% minoxidil, called Rogaine, for the specific treatment of androgenetic alopecia. Since the 1990s, numerous generic forms of minoxidil have become available to treat hair loss while the oral form is still used to treat high blood pressure.

Function:
(1).Promote hair regrowth.
(2).Slow or stop hair loss.
(3).Treat high blood pressure.

Application:
1. Applied on health care products
2. Applied on pharmerceutical industry
Minoxidil, applied topically, is widely used for the treatment of hair loss. It is effective in helping promote hair growth in bothmales and females with androgenic alopecia. About 40% of men experience hair regrowth after 3,6 months. Minoxidil must be used indefinitely for continued support of existing hair follicles and the maintenance of any experienced hair regrowth.It is the only topical product that is FDA approved for androgenic hair loss. Treatments usually include a 5% concentration solution that is designed for men, and a 2% concentration solution for women. The drug is available in the United Kingdomover-the-counter. Its effect in people with alopecia areata is unclear.